Benzylamine market seen growing at 6% CAGR through 2030

The benzylamine market is projected to rise from $62.59 billion in 2026 to $79.24 billion by 2030, driven by demand from pharmaceuticals, agrochemicals and industrial processing. Asia-Pacific is the largest market and is expected to grow the fastest as specialty chemical use expands.

Why it matters: - Benzylamine is a key intermediate used in pharmaceuticals, agrochemicals, resins and specialty coatings. - The market’s growth signals rising demand for specialty chemicals across manufacturing, healthcare and infrastructure-related uses. - The market is expected to keep expanding through 2030, with broader implications for chemical producers and downstream industries.

What happened: - The Business Research Company projected the global benzylamine market will grow from $62.59 billion in 2026 to $79.24 billion by 2030. - The forecast implies a 6.1% compound annual growth rate through 2030. - The report also said the market will rise from $59.14 billion in 2025 to $62.59 billion in 2026, a 5.8% CAGR. - Asia-Pacific was the largest regional market in 2025 and is expected to be the fastest-growing region during the forecast period. - The report was published June 23, 2026, in London. - Download a free sample of the benzylamine market report.

The details: - Benzylamine is an organic compound with the chemical formula C7H9N. - Benzylamine consists of a benzyl group attached to an amine group. - The compound appears as a colorless to pale yellow liquid with a mild, amine-like scent. - Benzylamine dissolves readily in many organic solvents. - Its reactive amine functional group makes it valuable as an intermediate in chemical synthesis. - The report cites growing demand for high-purity chemical compounds as a future support for market expansion. - The report also points to broader use of advanced pharmaceutical intermediates, expansion of global agrochemical production, sustainable chemical manufacturing and higher R&D spending in specialty chemicals. - Key trends include higher use of high-purity benzylamine in pharmaceutical synthesis, greater incorporation in agrochemical formulations, expanding industrial-grade production capacity and better storage and distribution technologies. - Pharmaceutical production in Europe reached €390 billion ($422.8 billion) in 2023, up from €363.3 billion ($393.9 billion) in 2022, according to EFPIA. - UK infrastructure investment reached £20.3 billion ($23.64 billion) in 2024, up 16.9% from 2023, according to the Office for National Statistics. - View the full benzylamine market report.

Between the lines: - The forecast ties benzylamine demand to two large end markets: drug manufacturing and industrial development. - That mix suggests growth is not dependent on a single use case, which can help stabilize demand over time. - The report’s focus on high-purity material and improved distribution points to a market moving toward more specialized and higher-value applications.

What's next: - Market growth will likely track pharmaceutical output, agrochemical production and infrastructure spending. - Asia-Pacific is positioned to remain the most important regional growth engine through 2030. - Producers will likely compete more on purity, capacity, logistics and process efficiency as demand broadens. - The report highlighted strategic tools in its 2026 edition, including market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards, market hotspot infographics and updated graphics and tables.